In India, one in every four people has high SGPT (liver injury), which equates to 22-25 per cent of the population, and fatty liver disease is on the rise in both rural and urban areas as a result of changing and sedentary lifestyles.
The berry-bearing black nightshade shrub has been proved to have a compound useful for treating liver cancer. The compound---Uttroside-B---isolated from the plant as part of an ongoing research programme of the Rajiv Gandhi Centre for Biotechnology (RGCB) has been granted the US Food and Drug Administration’s (FDA) ‘orphan drug’ designation.
Scientists have previously discovered several genes that drive the growth of HCC tumours, yet treatment benefit from approved drugs is still limited. In the new study, Villanueva and colleagues collected 44 tumour biopsies from 12 HCC patients.
Waist circumference takes into account belly fat, which is linked to several health risks including cardiovascular disease, type-2 diabetes and cancer, but fails to account for height.
The findings come from an analysis published in the New England Journal of Medicine and conducted by a team led by investigators at the Karolinska Institutet, in Sweden, and Massachusetts General Hospital (MGH).
Zoologists of MSU have identified a compound – carbon monoxide releasing molecule A1(CORM A1) – and documented positive results of this molecule on liver cells of humans and mice.
Individual hospitals record between 20 to 50 cases of liver diseases each month. Since liver disease develops silently and there are usually no symptoms in the initial stages, it is a big challenge to stop the progression of the disease.
Researchers at Karolinska Institute have now shown how a greater intake of inorganic nitrate can prevent the accumulation of fat in the liver.
The infection can also get transmitted through tattooing. But very few know about the deadly virus and take any precautionary measures like vaccination for the disease.
In a study published in the renowned Journal of Internal Medicine, Stefan Thurner and Peter Klimek from the Section for Science of Complex Systems and Kautzky-Willer were able to show that the risk can be eliminated using targeted precision medicine.
Around 80% of all liver cancer deaths and 1.4 million other deaths worldwide are caused by two diseases – hepatitis B and C.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
